P781: EVALUATION OF PEGCETACOPLAN TREATMENT SUCCESS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WITH AND WITHOUT BONE MARROW FAILURE: A MOVE TOWARDS INDIVIDUALIZED PATIENT TREATMENT
Jeff Szer,
Jens Panse,
Austin Kulasekararaj,
Monika Oliver,
Bruno Fattizzo,
Jun-Ichi Nishimura,
Johan Szamosi,
Regina Horneff,
Régis Peffault de Latour
Affiliations
Jeff Szer
1 Peter MacCallum Cancer Centre & Royal Melbourne Hospital Australia, Department of Clinical Haematology, Melbourne, Australia
Jens Panse
2 University Hospital RWTH Aachen, Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation; Centre for Integrated Oncology (CIO), Aachen, Germany
Austin Kulasekararaj
3 King’s College Hospital, National Institute of Health Research/Wellcome King’s Clinical Research Facility, Department of Haematological Medicine, London, United Kingdom
Monika Oliver
4 University of Alberta Hospital, Hemtatology & Apheresis Medicine, Edmonton, Canada
Bruno Fattizzo
5 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico; University of Milan, Hematology Unit; Department of Oncology and Hemato-Oncology, Milan, Italy
Jun-Ichi Nishimura
6 Osaka University Graduate School of Medicine, Department of Haematology and Oncology, Osaka, Japan
Johan Szamosi
7 Sobi Sweden, Stockholm, Sweden
Regina Horneff
7 Sobi Sweden, Stockholm, Sweden
Régis Peffault de Latour
8 French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Paris, France
